Taehong Park - Celltrion | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Biosimilar Trastuzumab (CT-P6) in Routine Clinical Practice in the Republic of Korea: a Real-World Post-Marketing Surveillance Study

EXPERT OPINION ON BIOLOGICAL THERAPYno. 4 (2024): 305-312

引用0浏览0引用

Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial

Justin Stebbing,Yauheni Baranau,Valery Baryash,Vladimir Moiseyenko,Dmytro Boliukh, Nicoleta Antone,Alexey Manikhas,Anatolii Chornobai,Taehong Park,Eric Hyungseok Baek, Jaeyong Lee,Jiin Choi,Nahyun Kim,Keumyoung Ahn, Sang Joon Lee,Sunghyun Kim

BioDrugs（2023）

引用0浏览0WOS引用

A Non-Interventional, Post-Marketing Surveillance Study Evaluating the Safety and Effectiveness of Biosimilar Rituximab (CT-P10) During Routine Clinical Practice in the Republic of Korea

Jae-Cheol Jo,Youngwoo Jeon,DaJung Kim,Deok-Hwan Yang,Won Sik Lee,Yoon Seok Choi,Jun Ho Yi,Dok Hyun Yoon,Jee Hyun Kong,Jung-Yoon Choe,SungHyun Kim,KeumYoung Ahn,TaeHong Park,Hana Ju,Soonbum Kwon,Seok-Goo Cho

Expert Opinion on Biological Therapy（2023）

引用0浏览0WOS引用

Safety and Effectiveness of Rituximab Biosimilar CT-P10 During Routine Clinical Practice: Final Analysis of a Post-Marketing Surveillance Study in the Republic of Korea

Seok-Goo Cho,Jae-Cheol Jo,Young-Woo Jeon,Dajung Kim,Deok-Hwan Yang,Won Sik Lee,Yoon Seok Choi,Jun Ho Yi,Dok Hyun Yoon,Jee Hyun Kong,Jung-yoon Choe,Sung Hyun Kim,Keum Young Ahn,TaeHong Park, Jeongah Park,Sangeun Han

Blood（2022）

引用0浏览0引用

Candidate Bevacizumab Biosimilar CT-P16 Versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial

Claire Verschraegen,Zoran Andric,Fedor Moiseenko,Tamta Makharadze,Sergii Shevnya, Alona Oleksiienko,Eduardo Yañez Ruiz,SungHyun Kim,KeumYoung Ahn,TaeHong Park,Sijin Park,Hana Ju,Yuichiro Ohe

BioDrugs（2022）

引用1浏览0WOS引用

Abstract CT551: Randomized Phase III Study Comparing the Efficacy and Safety of CT-P16, a New Biosimilar, to Reference Bevacizumab (avastin®) in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Yuichiro Ohe,Igor Bondarenko,Zoran Andric,Yuriy Ostapenko,Tudor Ciuleanu,Fedor Moiseenko,Tamta Makharadze,Sergii Shevnya,Alona Oleksiienko,Eduardo Yañez Ruiz,SungHyun Kim,KeumYoung Ahn,TaeHong Park,Sijin Park, JiEun Lee, MinJi Kim,Claire Verschraegen

Cancer research（2022）

引用0浏览0引用

Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin?) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC)

Yuichiro Ohe,Igor Bondarenko,Zoran Andric,Yuriy Ostapenko,Tudor Ciuleanu,Fedor Moiseenko,Tamta Makharadze,Sergii Shevnya, Alona Oleksiienko,Eduardo Yanez Ruiz,SungHyun Kim,KeumYoung Ahn,TaeHong Park,Sijin Park, Jieun Lee, Minji Kim,Claire Verschraegen

CANCER RESEARCHno. 12 (2022)

引用0浏览0引用

A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with Its Reference Product in Healthy Adult Males

Sang-Heon Cho,Seunghoon Han,Jong-Lyul Ghim,Moon-Suk Nam,Sunyoung Yu,Taehong Park,Sinhye Kim,Jihun Bae,Jae-Gook Shin

BioDrugs（2019）

引用15浏览0WOS引用

Research on Actinide Chemistry in Molten Salt

Taehong Park,Jei‐Won Yeon,Yong‐Hwan Cho,Jongyun Kim,Sang-Eun Bae,Jihye Kim,Kyuseok Song, Kwang-Soon Choi,Byungman Kang, Yongjoon Park

openalex（2017）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn